BIOCATALYSIS AND BIOTRANSFORMATION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1087832, encodeId=a9c1108e832bb, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087831, encodeId=023c108e83128, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559389, encodeId=3a9855938932, content=你好，需要版面费吗guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542672, encodeId=6f8a5426e215, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834389, encodeId=20db8343891b, content=太慢，无语..... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Mon Oct 31 08:37:37 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823279, encodeId=88948232e929, content=2012-04-27 submitted to bab/under review 2012-07-01 minor revision/revision submitted/under review 2012-08-13 minor revision 2012-09-05 revision submitted 2012-09-07 under review 2012-10-13 preliminarily accepted 2012-12-04 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5414099, createdName=ms4294801609865205, createdTime=Fri Dec 28 21:47:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=821634, encodeId=f44e8216347d, content=主要侧重新方法和新的化合物，审稿不是特别认真和负责，创新性要求不低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d45413963, createdName=ms2535923852153051, createdTime=Tue Sep 18 20:19:00 CST 2012, time=2012-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819532, encodeId=28a88195327c, content=这个期刊太慢了，从副主编来信说接受已经半年了，中间催过一次，主编回信说是接收了，但是之后又杳无音讯，不知道主编干什么去了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Wed May 16 10:01:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486768, encodeId=1b7c486e6880, content=2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67b656000, createdName=guoannan, createdTime=Sat Feb 18 10:28:00 CST 2012, time=2012-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816344, encodeId=d2438163444e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我的文章投出去两个半月，编辑回信让小修，感觉编辑还是蛮认真的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Sat Oct 01 10:52:00 CST 2011, time=2011-10-01, status=1, ipAttribution=)]

2021-12-29 乌云背后的幸福线

一般期刊要求几张图/几个表？

73 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1087832, encodeId=a9c1108e832bb, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087831, encodeId=023c108e83128, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559389, encodeId=3a9855938932, content=你好，需要版面费吗guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542672, encodeId=6f8a5426e215, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834389, encodeId=20db8343891b, content=太慢，无语..... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Mon Oct 31 08:37:37 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823279, encodeId=88948232e929, content=2012-04-27 submitted to bab/under review 2012-07-01 minor revision/revision submitted/under review 2012-08-13 minor revision 2012-09-05 revision submitted 2012-09-07 under review 2012-10-13 preliminarily accepted 2012-12-04 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5414099, createdName=ms4294801609865205, createdTime=Fri Dec 28 21:47:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=821634, encodeId=f44e8216347d, content=主要侧重新方法和新的化合物，审稿不是特别认真和负责，创新性要求不低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d45413963, createdName=ms2535923852153051, createdTime=Tue Sep 18 20:19:00 CST 2012, time=2012-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819532, encodeId=28a88195327c, content=这个期刊太慢了，从副主编来信说接受已经半年了，中间催过一次，主编回信说是接收了，但是之后又杳无音讯，不知道主编干什么去了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Wed May 16 10:01:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486768, encodeId=1b7c486e6880, content=2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67b656000, createdName=guoannan, createdTime=Sat Feb 18 10:28:00 CST 2012, time=2012-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816344, encodeId=d2438163444e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我的文章投出去两个半月，编辑回信让小修，感觉编辑还是蛮认真的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Sat Oct 01 10:52:00 CST 2011, time=2011-10-01, status=1, ipAttribution=)]

2021-12-28 rayms

什么是协同作用？什么是相加作用？两者有什么区别？

58 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1087832, encodeId=a9c1108e832bb, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087831, encodeId=023c108e83128, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559389, encodeId=3a9855938932, content=你好，需要版面费吗guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542672, encodeId=6f8a5426e215, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834389, encodeId=20db8343891b, content=太慢，无语..... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Mon Oct 31 08:37:37 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823279, encodeId=88948232e929, content=2012-04-27 submitted to bab/under review 2012-07-01 minor revision/revision submitted/under review 2012-08-13 minor revision 2012-09-05 revision submitted 2012-09-07 under review 2012-10-13 preliminarily accepted 2012-12-04 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5414099, createdName=ms4294801609865205, createdTime=Fri Dec 28 21:47:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=821634, encodeId=f44e8216347d, content=主要侧重新方法和新的化合物，审稿不是特别认真和负责，创新性要求不低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d45413963, createdName=ms2535923852153051, createdTime=Tue Sep 18 20:19:00 CST 2012, time=2012-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819532, encodeId=28a88195327c, content=这个期刊太慢了，从副主编来信说接受已经半年了，中间催过一次，主编回信说是接收了，但是之后又杳无音讯，不知道主编干什么去了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Wed May 16 10:01:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486768, encodeId=1b7c486e6880, content=2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67b656000, createdName=guoannan, createdTime=Sat Feb 18 10:28:00 CST 2012, time=2012-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816344, encodeId=d2438163444e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我的文章投出去两个半月，编辑回信让小修，感觉编辑还是蛮认真的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Sat Oct 01 10:52:00 CST 2011, time=2011-10-01, status=1, ipAttribution=)]

2018-07-20 铭记心中。。

你好，需要版面费吗guoannan 2012-02-18 10:28:00 发表:
2010 Impact Factor: 1.275
5-Year Impact Factor: 1.433

Read More: http://informahealthcare.com/journal/bab

guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275
5-Year Impact Factor: 1.433

Read More: http://informahealthcare.com/journal/bab

156 0

[GetPortalCommentsPageByObjectIdResponse(id=1087832, encodeId=a9c1108e832bb, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087831, encodeId=023c108e83128, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559389, encodeId=3a9855938932, content=你好，需要版面费吗guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542672, encodeId=6f8a5426e215, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834389, encodeId=20db8343891b, content=太慢，无语..... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Mon Oct 31 08:37:37 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823279, encodeId=88948232e929, content=2012-04-27 submitted to bab/under review 2012-07-01 minor revision/revision submitted/under review 2012-08-13 minor revision 2012-09-05 revision submitted 2012-09-07 under review 2012-10-13 preliminarily accepted 2012-12-04 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5414099, createdName=ms4294801609865205, createdTime=Fri Dec 28 21:47:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=821634, encodeId=f44e8216347d, content=主要侧重新方法和新的化合物，审稿不是特别认真和负责，创新性要求不低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d45413963, createdName=ms2535923852153051, createdTime=Tue Sep 18 20:19:00 CST 2012, time=2012-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819532, encodeId=28a88195327c, content=这个期刊太慢了，从副主编来信说接受已经半年了，中间催过一次，主编回信说是接收了，但是之后又杳无音讯，不知道主编干什么去了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Wed May 16 10:01:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486768, encodeId=1b7c486e6880, content=2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67b656000, createdName=guoannan, createdTime=Sat Feb 18 10:28:00 CST 2012, time=2012-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816344, encodeId=d2438163444e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我的文章投出去两个半月，编辑回信让小修，感觉编辑还是蛮认真的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Sat Oct 01 10:52:00 CST 2011, time=2011-10-01, status=1, ipAttribution=)]

2017-07-14 weiwei_zhu

反正就这个熊样,也不会有所变化,只要不跌,也就万幸了

175 0

[GetPortalCommentsPageByObjectIdResponse(id=1087832, encodeId=a9c1108e832bb, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087831, encodeId=023c108e83128, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559389, encodeId=3a9855938932, content=你好，需要版面费吗guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542672, encodeId=6f8a5426e215, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834389, encodeId=20db8343891b, content=太慢，无语..... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Mon Oct 31 08:37:37 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823279, encodeId=88948232e929, content=2012-04-27 submitted to bab/under review 2012-07-01 minor revision/revision submitted/under review 2012-08-13 minor revision 2012-09-05 revision submitted 2012-09-07 under review 2012-10-13 preliminarily accepted 2012-12-04 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5414099, createdName=ms4294801609865205, createdTime=Fri Dec 28 21:47:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=821634, encodeId=f44e8216347d, content=主要侧重新方法和新的化合物，审稿不是特别认真和负责，创新性要求不低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d45413963, createdName=ms2535923852153051, createdTime=Tue Sep 18 20:19:00 CST 2012, time=2012-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819532, encodeId=28a88195327c, content=这个期刊太慢了，从副主编来信说接受已经半年了，中间催过一次，主编回信说是接收了，但是之后又杳无音讯，不知道主编干什么去了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Wed May 16 10:01:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486768, encodeId=1b7c486e6880, content=2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67b656000, createdName=guoannan, createdTime=Sat Feb 18 10:28:00 CST 2012, time=2012-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816344, encodeId=d2438163444e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我的文章投出去两个半月，编辑回信让小修，感觉编辑还是蛮认真的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Sat Oct 01 10:52:00 CST 2011, time=2011-10-01, status=1, ipAttribution=)]

2016-10-31 ms4560175821706816

太慢，无语.....

117 0

[GetPortalCommentsPageByObjectIdResponse(id=1087832, encodeId=a9c1108e832bb, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087831, encodeId=023c108e83128, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559389, encodeId=3a9855938932, content=你好，需要版面费吗guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542672, encodeId=6f8a5426e215, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834389, encodeId=20db8343891b, content=太慢，无语..... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Mon Oct 31 08:37:37 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823279, encodeId=88948232e929, content=2012-04-27 submitted to bab/under review 2012-07-01 minor revision/revision submitted/under review 2012-08-13 minor revision 2012-09-05 revision submitted 2012-09-07 under review 2012-10-13 preliminarily accepted 2012-12-04 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5414099, createdName=ms4294801609865205, createdTime=Fri Dec 28 21:47:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=821634, encodeId=f44e8216347d, content=主要侧重新方法和新的化合物，审稿不是特别认真和负责，创新性要求不低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d45413963, createdName=ms2535923852153051, createdTime=Tue Sep 18 20:19:00 CST 2012, time=2012-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819532, encodeId=28a88195327c, content=这个期刊太慢了，从副主编来信说接受已经半年了，中间催过一次，主编回信说是接收了，但是之后又杳无音讯，不知道主编干什么去了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Wed May 16 10:01:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486768, encodeId=1b7c486e6880, content=2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67b656000, createdName=guoannan, createdTime=Sat Feb 18 10:28:00 CST 2012, time=2012-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816344, encodeId=d2438163444e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我的文章投出去两个半月，编辑回信让小修，感觉编辑还是蛮认真的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Sat Oct 01 10:52:00 CST 2011, time=2011-10-01, status=1, ipAttribution=)]

2012-12-28 ms4294801609865205

2012-04-27 submitted to bab/under review
2012-07-01 minor revision/revision submitted/under review
2012-08-13 minor revision
2012-09-05 revision submitted
2012-09-07 under review
2012-10-13 preliminarily accepted
2012-12-04

113 0

[GetPortalCommentsPageByObjectIdResponse(id=1087832, encodeId=a9c1108e832bb, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087831, encodeId=023c108e83128, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559389, encodeId=3a9855938932, content=你好，需要版面费吗guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542672, encodeId=6f8a5426e215, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834389, encodeId=20db8343891b, content=太慢，无语..... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Mon Oct 31 08:37:37 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823279, encodeId=88948232e929, content=2012-04-27 submitted to bab/under review 2012-07-01 minor revision/revision submitted/under review 2012-08-13 minor revision 2012-09-05 revision submitted 2012-09-07 under review 2012-10-13 preliminarily accepted 2012-12-04 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5414099, createdName=ms4294801609865205, createdTime=Fri Dec 28 21:47:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=821634, encodeId=f44e8216347d, content=主要侧重新方法和新的化合物，审稿不是特别认真和负责，创新性要求不低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d45413963, createdName=ms2535923852153051, createdTime=Tue Sep 18 20:19:00 CST 2012, time=2012-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819532, encodeId=28a88195327c, content=这个期刊太慢了，从副主编来信说接受已经半年了，中间催过一次，主编回信说是接收了，但是之后又杳无音讯，不知道主编干什么去了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Wed May 16 10:01:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486768, encodeId=1b7c486e6880, content=2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67b656000, createdName=guoannan, createdTime=Sat Feb 18 10:28:00 CST 2012, time=2012-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816344, encodeId=d2438163444e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我的文章投出去两个半月，编辑回信让小修，感觉编辑还是蛮认真的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Sat Oct 01 10:52:00 CST 2011, time=2011-10-01, status=1, ipAttribution=)]

2012-09-18 ms2535923852153051

主要侧重新方法和新的化合物，审稿不是特别认真和负责，创新性要求不低

122 0

[GetPortalCommentsPageByObjectIdResponse(id=1087832, encodeId=a9c1108e832bb, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087831, encodeId=023c108e83128, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559389, encodeId=3a9855938932, content=你好，需要版面费吗guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542672, encodeId=6f8a5426e215, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834389, encodeId=20db8343891b, content=太慢，无语..... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Mon Oct 31 08:37:37 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823279, encodeId=88948232e929, content=2012-04-27 submitted to bab/under review 2012-07-01 minor revision/revision submitted/under review 2012-08-13 minor revision 2012-09-05 revision submitted 2012-09-07 under review 2012-10-13 preliminarily accepted 2012-12-04 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5414099, createdName=ms4294801609865205, createdTime=Fri Dec 28 21:47:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=821634, encodeId=f44e8216347d, content=主要侧重新方法和新的化合物，审稿不是特别认真和负责，创新性要求不低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d45413963, createdName=ms2535923852153051, createdTime=Tue Sep 18 20:19:00 CST 2012, time=2012-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819532, encodeId=28a88195327c, content=这个期刊太慢了，从副主编来信说接受已经半年了，中间催过一次，主编回信说是接收了，但是之后又杳无音讯，不知道主编干什么去了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Wed May 16 10:01:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486768, encodeId=1b7c486e6880, content=2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67b656000, createdName=guoannan, createdTime=Sat Feb 18 10:28:00 CST 2012, time=2012-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816344, encodeId=d2438163444e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我的文章投出去两个半月，编辑回信让小修，感觉编辑还是蛮认真的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Sat Oct 01 10:52:00 CST 2011, time=2011-10-01, status=1, ipAttribution=)]

2012-05-16 ms4039545388929122

这个期刊太慢了，从副主编来信说接受已经半年了，中间催过一次，主编回信说是接收了，但是之后又杳无音讯，不知道主编干什么去了

122 0

[GetPortalCommentsPageByObjectIdResponse(id=1087832, encodeId=a9c1108e832bb, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087831, encodeId=023c108e83128, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559389, encodeId=3a9855938932, content=你好，需要版面费吗guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542672, encodeId=6f8a5426e215, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834389, encodeId=20db8343891b, content=太慢，无语..... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Mon Oct 31 08:37:37 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823279, encodeId=88948232e929, content=2012-04-27 submitted to bab/under review 2012-07-01 minor revision/revision submitted/under review 2012-08-13 minor revision 2012-09-05 revision submitted 2012-09-07 under review 2012-10-13 preliminarily accepted 2012-12-04 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5414099, createdName=ms4294801609865205, createdTime=Fri Dec 28 21:47:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=821634, encodeId=f44e8216347d, content=主要侧重新方法和新的化合物，审稿不是特别认真和负责，创新性要求不低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d45413963, createdName=ms2535923852153051, createdTime=Tue Sep 18 20:19:00 CST 2012, time=2012-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819532, encodeId=28a88195327c, content=这个期刊太慢了，从副主编来信说接受已经半年了，中间催过一次，主编回信说是接收了，但是之后又杳无音讯，不知道主编干什么去了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Wed May 16 10:01:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486768, encodeId=1b7c486e6880, content=2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67b656000, createdName=guoannan, createdTime=Sat Feb 18 10:28:00 CST 2012, time=2012-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816344, encodeId=d2438163444e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我的文章投出去两个半月，编辑回信让小修，感觉编辑还是蛮认真的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Sat Oct 01 10:52:00 CST 2011, time=2011-10-01, status=1, ipAttribution=)]

2012-02-18 guoannan

2010 Impact Factor: 1.275
5-Year Impact Factor: 1.433

Read More: http://informahealthcare.com/journal/bab

291 0

[GetPortalCommentsPageByObjectIdResponse(id=1087832, encodeId=a9c1108e832bb, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087831, encodeId=023c108e83128, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559389, encodeId=3a9855938932, content=你好，需要版面费吗guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=guoannan 2012-02-18 10:28:00 发表: 2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3znicMkicI94Wia7Jq1NMQAXYyWibHfz7XEaqq8FZufAK6QGDOgG5hoFDL0cp2dK7aMBYu8GMicticgP0/0, createdBy=94221957302, createdName=铭记心中。。, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542672, encodeId=6f8a5426e215, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834389, encodeId=20db8343891b, content=太慢，无语..... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Mon Oct 31 08:37:37 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=823279, encodeId=88948232e929, content=2012-04-27 submitted to bab/under review 2012-07-01 minor revision/revision submitted/under review 2012-08-13 minor revision 2012-09-05 revision submitted 2012-09-07 under review 2012-10-13 preliminarily accepted 2012-12-04 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5414099, createdName=ms4294801609865205, createdTime=Fri Dec 28 21:47:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=821634, encodeId=f44e8216347d, content=主要侧重新方法和新的化合物，审稿不是特别认真和负责，创新性要求不低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d45413963, createdName=ms2535923852153051, createdTime=Tue Sep 18 20:19:00 CST 2012, time=2012-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819532, encodeId=28a88195327c, content=这个期刊太慢了，从副主编来信说接受已经半年了，中间催过一次，主编回信说是接收了，但是之后又杳无音讯，不知道主编干什么去了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Wed May 16 10:01:00 CST 2012, time=2012-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486768, encodeId=1b7c486e6880, content=2010 Impact Factor: 1.275 5-Year Impact Factor: 1.433 Read More: http://informahealthcare.com/journal/bab, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67b656000, createdName=guoannan, createdTime=Sat Feb 18 10:28:00 CST 2012, time=2012-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816344, encodeId=d2438163444e, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我的文章投出去两个半月，编辑回信让小修，感觉编辑还是蛮认真的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a615414060, createdName=ms903640464789830, createdTime=Sat Oct 01 10:52:00 CST 2011, time=2011-10-01, status=1, ipAttribution=)]

2011-10-01 ms903640464789830

审稿速度:3.0 | 投稿命中率:25.0
经验分享：我的文章投出去两个半月，编辑回信让小修，感觉编辑还是蛮认真的，

111 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务